ESR1 and breast carcinoma: Regarding breast cancer subtypes, it was most abundant in those with TNBC (Figure 1D), while lowest in ER+ (estrogen receptor) and ER/PR+ (progesterone receptor) cancer (Supplemental Figure 2B).